131 related articles for article (PubMed ID: 1575822)
1. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH; Alfarsi S; Evans DJ
Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
[TBL] [Abstract][Full Text] [Related]
3. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin MA; Brunzell JD; Fitch WL; Krauss RM
Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
[TBL] [Abstract][Full Text] [Related]
4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
5. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
6. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
[TBL] [Abstract][Full Text] [Related]
10. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
11. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses.
Calabresi L; Donati D; Pazzucconi F; Sirtori CR; Franceschini G
Atherosclerosis; 2000 Feb; 148(2):387-96. PubMed ID: 10657575
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia.
Demacker PN; Veerkamp MJ; Bredie SJ; Marcovina SM; de Graaf J; Stalenhoef AF
Atherosclerosis; 2000 Dec; 153(2):483-90. PubMed ID: 11164438
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Haffner SM; Kushwaha RS; Hazzard WR
Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
[TBL] [Abstract][Full Text] [Related]
14. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
Hokanson JE; Austin MA; Zambon A; Brunzell JD
Arterioscler Thromb; 1993 Mar; 13(3):427-34. PubMed ID: 8443147
[TBL] [Abstract][Full Text] [Related]
15. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.
Juo SH; Bredie SJ; Kiemeney LA; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1998 Aug; 63(2):586-94. PubMed ID: 9683593
[TBL] [Abstract][Full Text] [Related]
16. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
[TBL] [Abstract][Full Text] [Related]
17. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia.
Hirano T; Nohtomi K; Sato Y; Kamata K; Ito Y
Atherosclerosis; 2009 Aug; 205(2):603-7. PubMed ID: 19201411
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
19. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
[TBL] [Abstract][Full Text] [Related]
20. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]